Smithkline Beecham (Cork) Limited
Records under this name other than patents Smithkline Beecham (Cork) Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Smithkline Beecham (Cork) Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,879,862 | PYRAZOLO[1,5-Alpha]PYRIMIDINYL Derivatives Useful as Corticotropin-Releasing Factor (CRF) Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,821,927 | Pharmaceutical Composition Formerly held In force · High confidence | In force | High confidence | |
| US 9,539,257 | Method of Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,004,742 | Method of Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 7,737,154 | CRF Receptor Antagonists and Methods Relating Thereto Formerly held Term ended Term ended Oct 19, 2026 · High confidence | Term ended | Term ended Oct 19, 2026 | High confidence |
| US 8,088,779 | Pyrazolo [1,5-Alpha] Pyrimidinyl Derivatives Useful as Corticotropin-Releasing Factor (CRF) Receptor Antagonists Formerly held Term ended Term ended Sep 28, 2026 · High confidence | Term ended | Term ended Sep 28, 2026 | High confidence |
| US 7,893,100 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment Formerly held Term ended Term ended Dec 30, 2024 · From the USPTO record | Term ended | Term ended Dec 30, 2024 | From the USPTO record |
| US 7,427,630 | Condensed N-heterocyclic compounds and their use as CRF receptor antagonists Formerly held Term ended Term ended Apr 7, 2024 · From the USPTO record | Term ended | Term ended Apr 7, 2024 | From the USPTO record |
| US 7,268,156 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment Formerly held Term ended Term ended Jun 27, 2023 · From the USPTO record | Term ended | Term ended Jun 27, 2023 | From the USPTO record |
| US 7,626,041 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment Formerly held Term ended Term ended Jun 27, 2023 · From the USPTO record | Term ended | Term ended Jun 27, 2023 | From the USPTO record |